{
  "docId": "019dd923-5ca1-7489-b639-9565d55e55d2",
  "docSlug": "22be84535de3e132",
  "documentTitle": "ovid-19 Special Primer (2020)",
  "authorId": "OliverWyman",
  "authorName": "Oliver Wyman",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.4,
  "pageNumber": 57,
  "pageCount": 61,
  "prevPage": 56,
  "nextPage": 58,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "photo"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-9565d55e55d2/57",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2#slide-57",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "In ADE, the weak binding of antibodies to a virus enhances its entry into human cells, causing more severe infection.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-d9ef-7323-a2de-76264f727562",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.2,
        "y": 0.3
      },
      "kind": "image",
      "text": "Diagram of SARS-CoV-2 virus structure",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23dccac5-f512-456c-85ca-a886b915df81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "list",
      "text": "Background on SARS/MERS, ADE risk, and clinical trial necessity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "905bb6cc-38b9-4407-959f-c847cbe40aae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Current vaccine candidates utilize different parts of SARS-CoV-2, mainly its genetic material (RNA) and surface proteins, to generate antibodies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "464aa0bc-a053-4192-a218-8ccea785f7d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Sources: Financial Times (link); Nature (link); Nature Reviews Microbiology (link); Scientific Animations (link); The New York Times (link).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1088be5e-bf24-4c23-85a3-eee7afe620e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "STILL, POTENTIAL COVID-19 VACCINES MUST BE THOROUGHLY TESTED FOR ANY NEGATIVE SIDE-EFFECTS BEFORE WIDESPREAD ROLLOUT",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63da02ad-678e-4b39-9e72-94ca1585d789",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "14536c6a-ca85-4de4-aa13-b301a747efcd",
      "evidence": "The slide presents a problem statement about COVID-19 vaccines and their potential negative side effects, which aligns with the problem statement canvas tool.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 60,
      "from": 55,
      "beatId": "d7250bf2-af3c-4bb0-b2fc-515e0efa5cd6",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The document provides evidence and data to support its claims and recommendations.",
      "position": 6,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}